Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study

Tekijä Chambord, Jeremy, Couzi, Lionel, Merville, Pierre, Moreau, Karine, Xuereb, Fabien, Djabarouti, Sarah
Julkaisussa Ther Adv Chronic Dis (2021)

Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?

Tekijä Ollivier, Julien, Carrié, Cédric, d’Houdain, Nicolas, Djabarouti, Sarah, Petit, Laurent, Xuereb, Fabien, Legeron, Rachel, Biais, Matthieu, Breilh, Dominique
Julkaisussa Antimicrob Agents Chemother (2019)

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

Tekijä Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Julkaistu 2010

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

Tekijä Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Julkaistu 2011

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases

Tekijä Streicher, Caroline, Djabarouti, Sarah, Xuereb, Fabien, Lazaro, Estibaliz, Legeron, Rachel, Bouchet, Stéphane, Greib, Carine, Breilh, Dominique, Pellegrin, Jean-Luc, Viallard, Jean-François
Julkaisussa Br J Clin Pharmacol (2014)